Toxicological Sciences 54, 3-18 (2000)
Copyright © 2000 by the Society of Toxicology
The Relative Bioavailability and Metabolism of Bisphenol A in Rats Is Dependent upon the Route of Administration
,1
* Toxicology and Environmental Research and Consulting, Dow Europe, Horgen, Switzerland;
Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, Michigan 48674; and
Health, Safety and Environment, Shell Chemical Company, Houston, Texas 77210
Bisphenol A (BPA) is used to produce polymers for food contact applications, thus there is potential for oral exposure of humans to trace amounts via the diet. BPA was weakly estrogenic in screening assays measuring uterine weight/response, although much higher oral doses of BPA were required to elicit a uterotropic response as compared to other routes of administration. The objective of this study was to determine if a route dependency exists in the pharmacokinetics and metabolism of 14C-labeled BPA following single oral (po), intraperitoneal (ip), or subcutaneous (sc) doses of either 10 or 100 mg/kg to Fischer 344 rats. Results indicated a marked route dependency in the pharmacokinetics of BPA. The relative bioavailability of BPA and plasma radioactivity was markedly lower following oral administration as compared to sc or ip administration. The major fraction of plasma radioactivity following oral dosing was the monoglucuronide conjugate of BPA (68–100% of plasma radioactivity). BPA was the major component in plasma at Cmax following sc or ip administration exceeded only by BPA-monoglucuronide in females dosed ip. Up to four additional unidentified metabolites were present only in the plasma of animals dosed ip or sc. One of these, found only following ip administration, was tentatively identified as the monosulfate conjugate of BPA. The monoglucuronide conjugate was the major urinary metabolite; unchanged BPA was the principal component excreted in feces. These results demonstrated a route dependency of BPA bioavailability in rats, with oral administration resulting in the lowest bioavailability, and offer an explanation for the apparent route differences in estrogenic potency observed for BPA.
Key Words: bisphenol A; bioavailability; absorption; metabolism; rats; route dependency.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. K. Kuester and I. G. Sipes Prediction of Metabolic Clearance of Bisphenol A (4,4 '-Dihydroxy-2,2-diphenylpropane) using Cryopreserved Human Hepatocytes Drug Metab. Dispos., October 1, 2007; 35(10): 1910 - 1915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Kuester, A. M. Solyom, V. P. Rodriguez, and I. G. Sipes The Effects of Dose, Route, and Repeated Dosing on the Disposition and Kinetics of Tetrabromobisphenol A in Male F-344 Rats Toxicol. Sci., April 1, 2007; 96(2): 237 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Smith and H. S. Taylor Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development FASEB J, January 1, 2007; 21(1): 239 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sasaki, A. Akahira, K.-i. Oshiman, T. Tsuchido, and Y. Matsumura Purification of Cytochrome P450 and Ferredoxin, Involved in Bisphenol A Degradation, from Sphingomonas sp. Strain AO1 Appl. Envir. Microbiol., December 1, 2005; 71(12): 8024 - 8030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Volkel, N. Bittner, and W. Dekant QUANTITATION OF BISPHENOL A AND BISPHENOL A GLUCURONIDE IN BIOLOGICAL SAMPLES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY Drug Metab. Dispos., November 1, 2005; 33(11): 1748 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Teeguarden, J. M. Waechter Jr., H. J. Clewell III, T. R. Covington, and H. A. Barton Evaluation of Oral and Intravenous Route Pharmacokinetics, Plasma Protein Binding, and Uterine Tissue Dose Metrics of Bisphenol A: A Physiologically Based Pharmacokinetic Approach Toxicol. Sci., June 1, 2005; 85(2): 823 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kitamura, T. Suzuki, S. Sanoh, R. Kohta, N. Jinno, K. Sugihara, S. Yoshihara, N. Fujimoto, H. Watanabe, and S. Ohta Comparative Study of the Endocrine-Disrupting Activity of Bisphenol A and 19 Related Compounds Toxicol. Sci., April 1, 2005; 84(2): 249 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Zoeller, R. Bansal, and C. Parris Bisphenol-A, an Environmental Contaminant that Acts as a Thyroid Hormone Receptor Antagonist in Vitro, Increases Serum Thyroxine, and Alters RC3/Neurogranin Expression in the Developing Rat Brain Endocrinology, February 1, 2005; 146(2): 607 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Inoue, A. Tsuruta, S. Kudo, T. Ishii, Y. Fukushima, H. Iwano, H. Yokota, and S. Kato BISPHENOL A GLUCURONIDATION AND EXCRETION IN LIVER OF PREGNANT AND NONPREGNANT FEMALE RATS Drug Metab. Dispos., January 1, 2005; 33(1): 55 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.'i. Yoshihara, T. Mizutare, M. Makishima, N. Suzuki, N. Fujimoto, K. Igarashi, and S. Ohta Potent Estrogenic Metabolites of Bisphenol A and Bisphenol B Formed by Rat Liver S9 Fraction: Their Structures and Estrogenic Potency Toxicol. Sci., March 1, 2004; 78(1): 50 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C Hutter, H. M. Luu, and C. S Kim A dynamic simulation of bisphenol A dosimetry in neuroendocrine organs Toxicology and Industrial Health, February 1, 2004; 20(1-5): 29 - 40. [Abstract] [PDF]
|
|
|
|
|
|
C. Kim, P. Sapienza, I. Ross, W Johnson, H. Luu, and J. Hutter Distribution of bisphenol A in the neuroendocrine organs of female rats Toxicology and Industrial Health, February 1, 2004; 20(1-5): 41 - 50. [Abstract] [PDF]
|
|
|
|
|
|
J. Y. Domoradzki, C. M. Thornton, L. H. Pottenger, S. C. Hansen, T. L. Card, D. A. Markham, M. D. Dryzga, R. N. Shiotsuka, and J. M. Waechter Jr. Age and Dose Dependency of the Pharmacokinetics and Metabolism of Bisphenol A in Neonatal Sprague-Dawley Rats Following Oral Administration Toxicol. Sci., February 1, 2004; 77(2): 230 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Domoradzki, L. H. Pottenger, C. M. Thornton, S. C. Hansen, T. L. Card, D. A. Markham, M. D. Dryzga, R. N. Shiotsuka, and J. M. Waechter Jr. Metabolism and Pharmacokinetics of Bisphenol A (BPA) and the Embryo-Fetal Distribution of BPA and BPA-Monoglucuronide in CD Sprague-Dawley Rats at Three Gestational Stages Toxicol. Sci., November 1, 2003; 76(1): 21 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kurebayashi, H. Betsui, and Y. Ohno Disposition of a Low Dose of 14C-Bisphenol A in Male Rats and Its Main Biliary Excretion as BPA Glucuronide Toxicol. Sci., May 1, 2003; 73(1): 17 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Thuillier, Y. Wang, and M. Culty Prenatal Exposure to Estrogenic Compounds Alters the Expression Pattern of Platelet-Derived Growth Factor Receptors {alpha} and {beta} in Neonatal Rat Testis: Identification of Gonocytes as Targets of Estrogen Exposure Biol Reprod, March 1, 2003; 68(3): 867 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Inoue, G. Yuki, H. Yokota, and S. Kato Bisphenol A Glucuronidation and Absorption in Rat Intestine Drug Metab. Dispos., January 1, 2003; 31(1): 140 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Pritchett, R. K. Kuester, and I. G. Sipes Metabolism of Bisphenol A in Primary Cultured Hepatocytes from Mice, Rats, and Humans Drug Metab. Dispos., November 1, 2002; 30(11): 1180 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ikezuki, O. Tsutsumi, Y. Takai, Y. Kamei, and Y. Taketani Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure Hum. Reprod., November 1, 2002; 17(11): 2839 - 2841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kurebayashi, R. Harada, R. K. Stewart, H. Numata, and Y. Ohno Disposition of a Low Dose of Bisphenol A in Male and Female Cynomolgus Monkeys Toxicol. Sci., July 1, 2002; 68(1): 32 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Tyl, C. B. Myers, M. C. Marr, B. F. Thomas, A. R. Keimowitz, D. R. Brine, M. M. Veselica, P. A. Fail, T. Y. Chang, J. C. Seely, et al. Three-Generation Reproductive Toxicity Study of Dietary Bisphenol A in CD Sprague-Dawley Rats Toxicol. Sci., July 1, 2002; 68(1): 121 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Markey, E. H. Luque, M. Munoz de Toro, C. Sonnenschein, and A. M. Soto In Utero Exposure to Bisphenol A Alters the Development and Tissue Organization of the Mouse Mammary Gland Biol Reprod, October 1, 2001; 65(4): 1215 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bayer, T. Colnot, and W. Dekant Disposition and Biotransformation of the Estrogenic Isoflavone Daidzein in Rats Toxicol. Sci., August 1, 2001; 62(2): 205 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.'i. Yoshihara, M. Makishima, N. Suzuki, and S. Ohta Metabolic Activation of Bisphenol A by Rat Liver S9 Fraction Toxicol. Sci., August 1, 2001; 62(2): 221 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Elsby, J. L. Maggs, J. Ashby, and B. K. Park Comparison of the Modulatory Effects of Human and Rat Liver Microsomal Metabolism on the Estrogenicity of Bisphenol A: Implications for Extrapolation to Humans J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 103 - 113. [Abstract] [Full Text]
|
|
|
|
|
|
A. D. Papaconstantinou, T. H. Umbreit, B. R. Fisher, P. L. Goering, N. T. Lappas, and K. M. Brown Bisphenol A-Induced Increase in Uterine Weight and Alterations in Uterine Morphology in Ovariectomized B6C3F1 Mice: Role of the Estrogen Receptor Toxicol. Sci., August 1, 2000; 56(2): 332 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kwon, D. B. Stedman, B. A. Elswick, R. C. Cattley, and F. Welsch Pubertal Development and Reproductive Functions of Crl:CD BR Sprague-Dawley Rats Exposed to Bisphenol A during Prenatal and Postnatal Development Toxicol. Sci., June 1, 2000; 55(2): 399 - 406. [Abstract] [Full Text] [PDF]
|
|